Asana, Inc. (ASAN), a notable player in the Technology sector, operates within the Software – Application industry, delivering a robust work management platform that facilitates task orchestration and strategic initiative..
Spok Holdings, Inc. (NASDAQ: SPOK) has gained the attention of savvy investors, particularly those with a keen eye on dividend yields and growth potential. As a player in the healthcare..
Compass Therapeutics, Inc. (NASDAQ: CMPX) is capturing the attention of investors with its promising biopharmaceutical portfolio and an astonishing potential upside of 302.44%. Specializing in the development of innovative antibody-based..
For investors seeking opportunities in the healthcare sector, Nyxoah SA (NASDAQ: NYXH) offers a compelling prospect. With its focus on innovative medical technology for treating obstructive sleep apnea, Nyxoah has..
Alumis Inc. (NASDAQ: ALMS), a burgeoning player in the biotechnology sector, presents a promising opportunity for investors seeking exposure to the healthcare industry. With its focus on developing innovative treatments..
Candel Therapeutics, Inc. (NASDAQ: CADL) stands out in the biotechnology sector with a focus on pioneering immunotherapies for cancer patients. As a clinical-stage biopharmaceutical company, Candel Therapeutics is making promising..
Health Catalyst, Inc. (NASDAQ: HCAT), a healthcare data and analytics provider, has captured investor attention with a potential upside of 32.49%, according to analyst ratings. As a company positioned in..
ZoomInfo Technologies Inc. (NASDAQ: GTM), with its $11.33 billion market cap, stands as a prominent player in the Technology sector, specifically within the Software – Application industry. Headquartered in Vancouver,..
Aurora Cannabis Inc. (NASDAQ: ACB) is a prominent player in the cannabis industry, headquartered in Edmonton, Canada. Known for its wide range of pharmaceutical-grade cannabis products, Aurora is at the..
Nerdy Inc. (NRDY), a prominent player in the technology sector operating within the software application industry, presents a compelling case for investors, especially those seeking opportunities in online learning platforms...
Quhuo Limited (NASDAQ: QH), a Chinese technology company specializing in gig economy services, stands at a pivotal moment for investors seeking to understand its recent performance and future potential. The..
NetClass Technology Inc (NASDAQ: NTCL), a burgeoning player in the technology sector, is catching the eye of investors intrigued by its innovative approach to online education. Despite facing a challenging..
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is drawing attention in the biotechnology sector with a compelling story that could interest investors looking for high-risk, high-reward opportunities. This clinical-stage biopharmaceutical company is..
Asure Software Inc (NASDAQ: ASUR) is making waves in the technology sector, particularly in the Software – Application industry, with a compelling potential upside of 56.92% according to current analyst..
Cytek Biosciences, Inc. (NASDAQ: CTKB), a prominent player in the healthcare sector specializing in medical devices, is garnering attention from investors due to its innovative cell analysis solutions and a..
Porch Group, Inc. (NASDAQ: PRCH) is capturing investor attention with its impressive rise in the technology sector, particularly in the software application industry. With a market capitalization of $1.7 billion,..
CytomX Therapeutics, Inc. (NASDAQ: CTMX), a cutting-edge player in the biotechnology industry, presents a compelling investment opportunity within the healthcare sector. Based in South San Francisco, California, CytomX is poised..
Tvardi Therapeutics, Inc. (TVRD), a U.S.-based clinical-stage biopharmaceutical company, has garnered significant attention from investors, thanks to its promising pipeline of therapies targeting fibrosis-driven diseases. With a market capitalization of..
For investors with an eye on the healthcare sector, UroGen Pharma Ltd. (NASDAQ: URGN) presents an intriguing opportunity, particularly given its focus on innovative treatments for urothelial and specialty cancers...
